DRUG/DEVICE

Centralized Lung Evaluation System

ROUTE OF ADMINISTRATION

Device

THERAPEUTIC PLATFORM

Organ Manufacturing

CLINICAL TRIAL

TERRITORY

Approximately 3,600 end-stage lung disease patients nationally are awaiting a transplant among 70 adult lung transplant centers in the U.S. Lung Bioengineering locations in Silver Spring, Maryland and Jacksonville, Florida have the ability to provide EVLP services to approximately 60% of U.S. adult lung transplant centers.

STATUS

Pivotal Trial

CAUTION: Investigational device. Limited by Federal law to investigational use.